Users online: 2521    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2018, Volume : 11, Issue : 9
First page : ( 3950) Last page : ( 3956)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2018.00726.6

New stability indicating ultrafast liquid chromatographic method for the determination of Tilorone in tablets

Bindu Gujju Hima*, Annapurna Mukthinuthalapati Mathrusri, Valli Duvvi Sri

Department of Pharmaceutical Analysis & Quality Assurance, GITAM Institute of Pharmacy, GITAM University, Visakhapatnam-530045, India

*Corresponding Author E-mail: bindureddy.frnd@gmail.com

Online published on 20 December, 2018.


A new stability indicating RP-UFLC method has been proposed for the determination of Tilorone in bulk and its tablet dosage forms. Chromatographic separation was achieved through C18 Agilent column(150 mm × 4.6 mm i.d., 3.5 μm particle size)using acetonitrile: 0.1% triethylamine (pH adjusted to 3.2 with orthophosphoric acid)mixture asmobile phase. The UFLC system was monitored at 270 nm on isocratic mode withflow rate 0.5 mL/min and the total run time is 10mins. The method was validated and forced degradation studies were performed. Tilorone has obeyed Beer-Lambert's law0.1–20 μg/mL with correlation coefficient 0.9999. The LOD and LOQare found to be 0.0104and 0.0316 μg/mL respectively. Tiloronewas subjected to stress degradationstudies. The UFLC method is accurate, precise, sensitive, and reproducible forthe estimation of Tiloronein tablets. The method was validated as per ICH guidelines and found to be specific as the degradants were well separated without interfering with the drug peak.



Tilorone, Stability Indicating, UFLC, ICH guidelines.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
597,850,902 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.